These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Relaxation of rat thoracic aorta induced by 2,2',2''-tripyridine.
    Author: Hsu KS, Lin-Shiau SY.
    Journal: Eur J Pharmacol; 1994 Jan 03; 270(1):89-95. PubMed ID: 8157085.
    Abstract:
    The pharmacological and toxicological activity of 2,2',2''-tripyridine was determined in rat thoracic aorta. 2,2',2''-Tripyridine inhibited norepinephrine (3 microM)-induced phasic and tonic contractions in the thoracic aorta as well as the endothelium-denuded aorta of the rat. The tonic pre-contraction elicited by norepinephrine was also relaxed by the addition of 2,2',2''-tripyridine and this relaxing effect was not affected by indomethacin (20 microM) but partially antagonized by methylene blue (50 microM). In high-K+ medium (80 mM), 2,2',2''-tripyridine inhibited the Ca2+ concentration dependent vasocontraction. Moreover, in Ca(2+)-free medium, the phasic contraction induced by either norepinephrine (3 microM) or caffeine (10 mM) was also suppressed by 2,2',2''-tripyridine. Although the cAMP level of rat aorta was not changed by 2,2',2''-tripyridine, cGMP level was significantly increased by 2,2',2''-tripyridine. The increase in cGMP level caused by 2,2',2''-tripyridine was completely blocked by methylene blue (50 microM). The 45Ca2+ influx elicited by either norepinephrine or high-K+ was inhibited by 2,2',2''-tripyridine. All of these findings indicate that 2,2',2''-tripyridine relaxes rat thoracic aorta by virtue of its Ca(2+)-channel blocking properties and by elevating cGMP levels in vascular smooth muscle.
    [Abstract] [Full Text] [Related] [New Search]